Skip to content
Credit reportVerdict and grounds
Made on 22-11-2026 at 14:54
Reference CK-0473676932-20261122

KITOZYME

ActivePublic limited company0473.676.932Rue de Milmort 680, 4040 Herstal
Manufacture of chemicals and chemical products (NACE 20140) · founded in 2001 · 29 employees on 31-12-2025 · 8th largest company by equity in the province of Liège, Chemicals sector

Sources: the KBO register on 22-11-2026; the National Bank, 2025 annual accounts filed on 02-07-2026; the Belgian Official Gazette, latest deed of 30-09-2026.

Credit verdict
Checked score 2025
The score, from 0 to 100, reflects the bankruptcy probability and the standing among sector peers.
Bankruptcy probability within 12 months
The median of 147 small companies in the chemicals sector (NACE 20) is 0.2%.
Turnover
€7.1m
▲ 6.3% against 2024
Net result
€824,661
▼ 24.9% against 2024
Equity
€17.2m
▲ 7.4% against 2024
Supplier credit
25 days
25 days shorter than in 2024

Grounds

the facts the verdict rests on, each with its source
  1. In 2025, KITOZYME had a turnover of €7.1m and a net profit of €824,661.Annual accounts 2025 page 2
  2. Equity stands at €17.2m, or 76.9% of the balance sheet total of €22.4m. The solvency of 76.9% is higher than at 78% of the 197 companies filing abbreviated accounts in chemicals (NACE 20) in 2025.Annual accounts 2025 page 2
  3. Suppliers waited 25 days on average for their money in 2025, 25 days shorter than in 2024. Customers paid after 75 days.Annual accounts 2024 and 2025 page 2
  4. The last five annual accounts came in on time. The 2025 accounts were filed 29 days before the end of the term.National Bank, filing of 02-07-2026 page 5

Representation

Two directors jointly represent KITOZYME.

Articles of association, Belgian Official Gazette of 17-10-2016, deed 16142835

Ownership

holds 44% of the shares. Its equity stood at €8.8m on 31-12-2025. There are 3 other shareholders.

Annual accounts 2025

KITOZYME · 0473.676.932 · credit report of 22-11-2026Page 1 of 6
KITOZYME0473.676.932 · report of 22-11-2026

Financial situation

Annual accounts 2021 to 2025, as filed with the National Bank

Turnover and net resultin €m

20215.420227.720236.820246.720257.120214.820221.520231.220241.120250.8
turnovernet result

Equity and debtsin €m

2021202220232024202517.24.8
equitydebts

Payment termsin days

306090120202120222023202420252575
suppliers waitcustomers pay
Financial year20212022202320242025Trend
Results
Turnover€5.4m€7.7m€6.8m€6.7m€7.1m
Operating result€4.9m€1.3m€942,436€831,719€666,147
Net result€4.8m€1.5m€1.2m€1.1m€824,661
Balance sheet at the closing date
Equity€12.4m€13.8m€15.0m€16.0m€17.2m
Debts€5.1m€4.8m€4.1m€4.7m€4.8m
Debts due after more than one year€2.3m€1.4m€682,448€227,800€1.1m
Debts due within one year€2.8m€3.3m€3.5m€4.4m€3.7m
Cash€2.8m€1.6m€533,599€1.3m€635,010
Balance sheet total€17.8m€18.8m€19.6m€21.0m€22.4m
Operations
Employees in full-time equivalents28.630.528.227.327.2
Customer credit81 days107 days124 days91 days75 days
Supplier credit62 days53 days64 days50 days25 days
Ratios
Solvency69.6%73.2%76.6%76.1%76.9%
Liquidity1.961.921.891.692.04

Source: Annual accounts 2025, abbreviated format, filed on 02-07-2026 (2026-00264356); Annual accounts 2024, full format, filed on 30-06-2025 (2025-00233376); Annual accounts 2021 to 2023, filed from 28-06-2024 to 09-12-2024 (2024-00616773, 2024-00616584, 2024-00222042).

The operating result of 2025 is 20% lower than in 2024.

The 2025 annual accounts state no amount of overdue tax or social security (RSZ) debts.

KITOZYME · 0473.676.932 · credit report of 22-11-2026Page 2 of 6
KITOZYME0473.676.932 · report of 22-11-2026

Board, signature and ownership

Position on 22-11-2026 according to the deeds in the Belgian Official Gazette and the annual accounts

Who represents the company

Two directors jointly represent KITOZYME.

Articles of association, Belgian Official Gazette of 17-10-2016, deed 16142835

Board

five directors and one statutory auditor in office
Chair of the board and directorrenewed by deed of 03-10-2012
6-year term from 2026deed of 03-10-2012
Directorcurrent term since 20-06-2025
2-year term from 2026deed of 28-05-2009
Directorcurrent term since 20-06-2025
2-year term from 2026deed of 22-09-2021
Directorsince 20-06-2025
2-year term from 2026deed of 03-10-2012
Directorrenewed by deed of 30-08-2019
6-year term from 2026deed of 30-08-2019
Statutory auditorappointed by deed of 18-08-2014
3-year term from 2026deed of 18-08-2014

also sits on the boards of 8 other companies. also sits on the boards of 252 other companies. also sits on the boards of 253 other companies. also sits on the boards of 3 other companies.

Ownership and group

Shareholders

holds 44% of the shares. Its equity stood at €8.8m on 31-12-2025. holds 18.48% of the shares. Its equity stood at €4.98bn on 31-12-2025. held 18% of the shares. Since the merger of 09-01-2023, these shares have been held by . The equity of stood at €4.98bn on 31-12-2025. There is one other shareholder.

Annual accounts 2025, annual accounts 2025 of

Board changes

, , , , and (statutory auditor). General meeting of 16-06-2026.

Gazette, deed 26121691

, and . , and act as permanent representatives. General meeting of 21-06-2024.

Gazette, deed 24153466

, and act as permanent representatives. and (statutory auditor). General meeting of 16-06-2023.

Gazette, deed 23129092
KITOZYME · 0473.676.932 · credit report of 22-11-2026Page 3 of 6
KITOZYME0473.676.932 · report of 22-11-2026

Holdings

KITOZYME has 2 holdings (own 2025 accounts).

Country Company Equity Result
Belgium 2
BE 20% €9.0m result €2.2m
BE 75.88% €1.1m result -€1.7m

Source: List of holdings in its own 2025 accounts. Every holding stands with its own latest accounts.

KITOZYME · 0473.676.932 · credit report of 22-11-2026Page 4 of 6
KITOZYME0473.676.932 · report of 22-11-2026

Events and comparison

The last 24 months, newest first

Annual accounts 2025 filed, 29 days before the deadline.

NBB filing

Annual accounts 2024 filed, 31 days before the deadline.

NBB filing

Corrected annual accounts 2021 filed.

NBB filing

Corrected annual accounts 2022 filed.

NBB filing

Comparable companies, two years later

In July 2024, 14,780 companies had the same profile as KITOZYME has now: small, 20 years or older, solvency 30% or more and a profit under 5% of the balance sheet. Two years later 96.2% were still trading, 3.6% had stopped another way and 0.2% had gone bankrupt.

still trading 96.2% stopped another way 3.6% bankrupt 0.2%

The return on assets of KITOZYME, 3.7%, is higher than at 49% of the 197 companies filing abbreviated accounts in chemicals (NACE 20) in 2025.

Other findings

Peppol

Reachable for e-invoices, under 0208:0473676932.

Sanctions lists

Staff

29 employees on 31-12-2025, 27.2 full-time equivalents on average over the year.

KITOZYME · 0473.676.932 · credit report of 22-11-2026Page 5 of 6
KITOZYME0473.676.932 · report of 22-11-2026

Sources and method

Where each fact in this report comes from

SourceWhatDateReference
KBO registerRegistration, legal situation, activity, establishment units22-11-2026KBO 0473.676.932
National Bank of BelgiumAnnual accounts 2025, abbreviated format02-07-20262026-00264356
National Bank of BelgiumAnnual accounts 2024, full format30-06-20252025-00233376
National Bank of BelgiumAnnual accounts 2021 to 202328-06-2024 to 09-12-20242024-00616773, 2024-00616584, 2024-00222042
Belgian Official GazetteBoard30-09-2026deed 26121691
Belgian Official GazetteBoard24-10-2024deed 24153466
Belgian Official GazetteBoard10-10-2023deed 23129092
Belgian Official GazetteArticles of association with the signing rule17-10-2016deed 16142835
Peppol DirectoryRegistration for e-invoices0208:0473676932
Sanctions lists EU, UN, US (OFAC) and UKComparison of the name19-11-2026
CheckedChecked score, bankruptcy probability, credit, comparable companies21-11-2026bankruptcy model of 21 November 2026

Method

Checked score. A number from 0 to 100. The bankruptcy probability sets the class, from Critical to Excellent; within the class, the comparison with sector peers on solvency, liquidity, profitability and growth counts for half.

Bankruptcy probability. The probability that the company goes bankrupt within 12 months, estimated from the KBO register, the annual accounts and the Gazette with the bankruptcy model of 21 November 2026, computed on 21-11-2026.

Credit. The credit is a tenth of equity, weighted by the score, and never more than a tenth of turnover. With negative equity there is no credit.

Payment terms. Supplier credit is the debt to suppliers divided by the year's purchases, times 365. Customer credit is the same for what customers still owe, against turnover.

Comparable companies. Companies of the same size, age, solvency and profitability at an earlier date, followed two years later in the KBO register and the Gazette.

The scores and ratios are Checked's own calculations, not a credit decision.

KITOZYME · 0473.676.932 · credit report of 22-11-2026Page 6 of 6